Pharmagen, Inc.
PHRX
Rank in Stocks
#34793
Pharmagen, Inc., a pharmaceutical company located in Silver Spring, Maryland,... Pharmagen, Inc., a pharmaceutical company located in Silver Spring, Maryland, operates primarily as a distributor within the U.S. healthcare market. It provides a diverse range of specialty drugs to various medical clients, including hospitals, acute care centers, surgical facilities, and other healthcare practitioners nationwide. The company's offerings encompass sourcing and distributing specialty pharmaceuticals, blood plasma derivatives, unique medical products, vaccines, anti-infectives, and often hard-to-find medications. A key area of its expertise lies in plasma derivatives, which are vital for managing severe conditions such as cancer, hemophilia, rheumatoid arthritis, multiple sclerosis, blood disorders, hepatitis, and HIV. Additionally, Pharmagen supplies specialized products designed to treat respiratory, oncological, cardiovascular, and hormonal ailments. Beyond its core distribution activities, Pharmagen also produces and sells its own health supplements, notably Clotamin, an over-the-counter multivitamin formulated specifically for individuals undergoing Warfarin therapy. The company further serves its existing customers by supplying traditional pharmaceuticals, including a variety of antibiotics, vaccines, and other oral and injectable medicines. With a specialized focus on drug formulation, Pharmagen Inc. adopted its current name in January 2013, having previously operated as Sunpeaks Ventures, Inc.
Share Price
$0.00001
Last synced: 2026-11-06
Market Cap
$5.17K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Pharmagen, Inc. (PHRX)
Category
Healthcare
Operating Margin for Pharmagen, Inc. (PHRX)
Operating Margin as of November 2026 TTM: -44.86%
According to Pharmagen, Inc.'s latest financial reports, its current operating margin (TTM) is -44.86%. At the end of 2013 the company had an operating margin of -44.86%.
Operating Margin history for Pharmagen, Inc. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -44.86% | 0.00% |
| 2013 | -44.86% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 1.62% | -100.04% |
US
|
|
| 1.30% | -100.03% |
US
|
|
| 1.03% | -100.02% |
US
|
|
| 0.91% | -100.02% |
US
|
|
| 9.21% | -100.21% |
AU
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Pharmagen, Inc.'s operating margin
What is Pharmagen, Inc.'s operating margin?
Pharmagen, Inc.'s operating margin is -44.86%, as of Nov 2026.
How does Pharmagen, Inc.'s operating margin compare with similar companies?
Pharmagen, Inc.'s operating margin (-44.86%) is lower than that of all 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.